1. Home
  2. PDI vs CYTK Comparison

PDI vs CYTK Comparison

Compare PDI & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PIMCO Dynamic Income Fund

PDI

PIMCO Dynamic Income Fund

HOLD

Current Price

$18.22

Market Cap

7.6B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.34

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDI
CYTK
Founded
2012
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
PDI
CYTK
Price
$18.22
$63.34
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$84.81
AVG Volume (30 Days)
1.5M
1.8M
Earning Date
01-01-0001
02-26-2026
Dividend Yield
13.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$87,211,000.00
Revenue This Year
N/A
$341.94
Revenue Next Year
N/A
$75.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2609.26
52 Week Low
$15.45
$29.31
52 Week High
$19.60
$70.98

Technical Indicators

Market Signals
Indicator
PDI
CYTK
Relative Strength Index (RSI) 59.73 49.19
Support Level $18.02 $62.13
Resistance Level $18.17 $65.88
Average True Range (ATR) 0.08 2.59
MACD 0.01 0.07
Stochastic Oscillator 78.85 54.84

Price Performance

Historical Comparison
PDI
CYTK

About PDI PIMCO Dynamic Income Fund

PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: